{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:22:59Z","timestamp":1780964579931,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12010-022-04207-w","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T07:03:07Z","timestamp":1668841387000},"page":"1983-1998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-2434","authenticated-orcid":false,"given":"Sivaraman","family":"Dhanasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Pushparaj","family":"Selvadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Sundar","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"1","key":"4207_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"JCO Sardi","year":"2013","unstructured":"Sardi, J. C. O., Scorzoni, L., Bernardi, T., et al. (2013). Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology, 62(1), 10\u201324.","journal-title":"Journal of Medical Microbiology"},{"issue":"11","key":"4207_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","volume":"3","author":"P Eggimann","year":"2003","unstructured":"Eggimann, P., Garbino, J., & Pittet, D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infectious Diseases, 3(11), 685\u2013702.","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"4207_CR3","first-page":"350","volume":"9","author":"ZA Bukhary","year":"2008","unstructured":"Bukhary, Z. A. (2008). Candiduria: A review of clinical significance and management. Saudi Journal of Kidney Diseases and Transplantation, 9(3), 350\u2013360.","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"key":"4207_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","volume":"67","author":"JR Naglik","year":"2003","unstructured":"Naglik, J. R., Challacombe, S. J., & Hube, B. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiology and Molecular Biology Reviews, 67, 400\u2013428.","journal-title":"Microbiology and Molecular Biology Reviews"},{"key":"4207_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1462-5822.2002.00206.x","volume":"4","author":"P Sundstrom","year":"2002","unstructured":"Sundstrom, P. (2002). Adhesion in Candida spp. Cellular Microbiology, 4, 461\u2013469.","journal-title":"Cellular Microbiology"},{"key":"4207_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1369-5274(01)00275-2","volume":"4","author":"H Liu","year":"2001","unstructured":"Liu, H. (2001). Transcriptional control of dimorphism in Candida albicans. Current Opinion in Microbiology, 4, 728\u2013735.","journal-title":"Current Opinion in Microbiology"},{"key":"4207_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1128\/iai.64.2.466-471.1996","volume":"64","author":"FD Bernardis","year":"1996","unstructured":"Bernardis, F. D., Chiani, P., Ciccozzi, M., Pellegrini, G., Ceddia, T., Offizzi, G. D., et al. (1996). Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infection and Immunity, 64, 466\u2013471.","journal-title":"Infection and Immunity"},{"issue":"1","key":"4207_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/biom4010117","volume":"4","author":"JL Adrio","year":"2014","unstructured":"Adrio, J. L., & Demain, A. L. (2014). Microbial enzymes: Tools for biotechnological processes. Biomolecules, 4(1), 117\u201339.","journal-title":"Biomolecules"},{"key":"4207_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L., & Groom, C. R. (2002). The druggable genome. Nature Reviews. Drug Discovery, 1, 727\u2013730.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"4207_CR10","first-page":"1","volume":"13","author":"T Absar","year":"2022","unstructured":"Absar, T., Yasir, B., & Asad, U. K. (2022). Repurposing of antibiotics: Sense or non-sense. Frontiers in Pharmacology, 13, 1\u201313.","journal-title":"Frontiers in Pharmacology"},{"issue":"23","key":"4207_CR11","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.3390\/ijms20235844","volume":"20","author":"G Annunziato","year":"2019","unstructured":"Annunziato, G. (2019). Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: A review. International Journal of Molecular Sciences, 20(23), 5844.","journal-title":"International Journal of Molecular Sciences"},{"key":"4207_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/IDR.S287792","volume":"14","author":"IA Dutescu","year":"2021","unstructured":"Dutescu, I. A., & Hillier, S. A. (2021). Encouraging the development of new antibiotics: Are financial incentives the right way forward? A systematic review and case study. Infection and Drug Resistance, 14, 415\u2013434.","journal-title":"Infection and Drug Resistance"},{"issue":"1","key":"4207_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins, S., Mestres, J., & Testa, B. (2007). In silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling. British Journal of Pharmacology, 152(1), 9\u201320.","journal-title":"British Journal of Pharmacology"},{"issue":"7019","key":"4207_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nature03197","volume":"432","author":"BK Shoichet","year":"2004","unstructured":"Shoichet, B. K. (2004). Virtual screening of chemical libraries. Nature, 432(7019), 862\u2013865.","journal-title":"Nature"},{"key":"4207_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13020-018-0190-0","volume":"13","author":"F Yi","year":"2018","unstructured":"Yi, F., Li, L., Xu, L. J., et al. (2018). In silico approach in reveal traditional medicine plants pharmacological material basis. Chinese Medicine, 13, 33.","journal-title":"Chinese Medicine"},{"key":"4207_CR16","unstructured":"Mahanthesh, M. T., Ranjith, D., Raghavendra, Y., et al. (2020). Swiss ADME prediction of phytochemicals present in Butea monosperma (Lam.) Taub. Journal of Pharmacognosy and Phytochemistry, 9(3), 1799\u20131809."},{"key":"4207_CR17","doi-asserted-by":"publisher","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush, K., & Bradford, P. A. (2016). \u03b2-Lactams and \u03b2-lactamase inhibitors: An overview. Cold Spring Harbor Perspectives in Medicine, 6, a025247.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"1","key":"4207_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijantimicag.2017.09.012","volume":"51","author":"M Lu","year":"2018","unstructured":"Lu, M., Yu, C., Cui, X., et al. (2018). Gentamicin synergises with azoles against drug-resistant Candida albicans. Int J Antimicrob Agents, 51(1), 107\u2013114.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"4207_CR19","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3389\/fmicb.2018.03142","volume":"31","author":"M Lu","year":"2019","unstructured":"Lu, M., Yang, X., Yu, C., et al. (2019). Linezolid in combination with azoles induced synergistic effects against candida albicans and protected galleria mellonella against experimental candidiasis. Frontiers in Microbiology, 31(9), 3142.","journal-title":"Frontiers in Microbiology"},{"key":"4207_CR20","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3389\/fmicb.2017.01956","volume":"8","author":"J Chaillot","year":"2017","unstructured":"Chaillot, J., Tebbji, F., Garcia, C., et al. (2017). pH-dependant antifungal activity of valproic acid against the human fungal pathogen Candida albicans. Frontiers in Microbiology, 8, 1956.","journal-title":"Frontiers in Microbiology"},{"issue":"4","key":"4207_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0025-7125(16)30043-8","volume":"79","author":"ME Falagas","year":"1995","unstructured":"Falagas, M. E., & Gorbach, S. L. (1995). Clindamycin and metronidazole. Medical Clinics of North America, 79(4), 845\u201367.","journal-title":"Medical Clinics of North America"},{"issue":"9","key":"4207_CR22","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","volume":"6","author":"DC Hooper","year":"2016","unstructured":"Hooper, D. C., & Jacoby, G. A. (2016). Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance. Cold Spring Harbor Perspectives in Medicine, 6(9), a025320.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5","key":"4207_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acs.jmedchem.9b01279","volume":"63","author":"GB Concepcion","year":"2020","unstructured":"Concepcion, G. B., Diana, R., Marina, P., et al. (2020). \u03b2-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs. Journal of Medicinal Chemistry, 63(5), 1859\u20131881.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"4207_CR24","doi-asserted-by":"publisher","first-page":"a025262","DOI":"10.1101\/cshperspect.a025262","volume":"7","author":"LL Silver","year":"2017","unstructured":"Silver, L. L. (2017). Fosfomycin: Mechanism and resistance. Cold Spring Harbor Perspectives in Medicine, 7(2), a025262.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"4207_CR25","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/prot.22021","volume":"72","author":"C Borelli","year":"2008","unstructured":"Borelli, C., Ruge, E., Lee, J. H., et al. (2008). X-ray structures of Sap1 and Sap5: Structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins, 72, 1308\u20131319.","journal-title":"Proteins"},{"key":"4207_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1515\/bmc.2010.022","volume":"1","author":"SA Hollingsworth","year":"2010","unstructured":"Hollingsworth, S. A., & Karplus, P. A. (2010). A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins. Biomolecular Concepts, 1, 271\u2013283.","journal-title":"Biomolecular Concepts"},{"key":"4207_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J., Headd, J. J., Moriarty, N. W., et al. (2018). MolProbity: More and better reference data for improved all-atom structure validation. Protein Science, 27, 293\u2013315.","journal-title":"Protein Science"},{"key":"4207_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s13104-015-1483-3","volume":"8","author":"R Chaudhari","year":"2015","unstructured":"Chaudhari, R., & Li, Z. (2015). PyMine: A PyMOL plugin to integrate and visualize data for drug discovery. BMC Research Notes, 8, 517.","journal-title":"BMC Research Notes"},{"key":"4207_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"D Antoine","year":"2017","unstructured":"Antoine, D., Olivier, M., & Vincent, Z. (2017). Swiss ADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Science and Reports, 7, 1\u201313.","journal-title":"Science and Reports"},{"key":"4207_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jcc.20222","volume":"26","author":"AE Cho","year":"2005","unstructured":"Cho, A. E., Guallar, V., Berne, B. J., et al. (2005). Importance of accurate charges in molecular docking: Quantum mechanical\/molecular mechanical (QM\/MM) approach. Journal of Computational Chemistry, 26, 915\u2013931.","journal-title":"Journal of Computational Chemistry"},{"key":"4207_CR31","doi-asserted-by":"publisher","first-page":"e0174336","DOI":"10.1371\/journal.pone.0174336","volume":"12","author":"HS Muniz","year":"2017","unstructured":"Muniz, H. S., & Nascimento, A. S. (2017). Towards a critical evaluation of an empirical and volume-based solvation function for ligand docking. PLoS One, 12, e0174336.","journal-title":"PLoS One"},{"key":"4207_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455\u2013461.","journal-title":"Journal of Computational Chemistry"},{"key":"4207_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"F Stefano","year":"2016","unstructured":"Stefano, F., Ruth, H., Michael, E. P., et al. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11, 905\u2013919.","journal-title":"Nature Protocols"},{"key":"4207_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini, A., Hogberg, L. D., Plachouras, D., et al. (2019). Attributable deaths and disability-adjusted life-years caused by infections with antibioticresistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. The Lancet Infectious Diseases, 19, 56\u201366.","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"4207_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin, F., Gago, S., Oladele, R. O., et al. (2017). Global and multi-national prevalence of fungal diseases-estimate precision. Journal of Fungi (Basel), 3(4), 57.","journal-title":"Journal of Fungi (Basel)"},{"issue":"2","key":"4207_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/CMR.00076-09","volume":"23","author":"JM Achkar","year":"2010","unstructured":"Achkar, J. M., & Fries, B. C. (2010). Candida infections of the genitourinary tract. Clinical Microbiology Reviews, 23(2), 253\u201373.","journal-title":"Clinical Microbiology Reviews"},{"key":"4207_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00629","volume":"8","author":"L Mukaremera","year":"2017","unstructured":"Mukaremera, L., Lee, K. K., Mora-Montes, H. M., et al. (2017). Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition. Frontiers in Immunology, 8, 1.","journal-title":"Frontiers in Immunology"},{"key":"4207_CR38","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3389\/fmicb.2018.01996","volume":"9","author":"HOJ Morad","year":"2018","unstructured":"Morad, H. O. J., Wild, A. M., Wiehr, S., et al. (2018). Pre-clinical imaging of invasive candidiasis using immunoPET\/MR. Frontiers in Microbiology, 9, 1996.","journal-title":"Frontiers in Microbiology"},{"key":"4207_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/21505594.2020.1748930","volume":"11","author":"H Chen","year":"2020","unstructured":"Chen, H., Zhou, X., Ren, B., et al. (2020). The regulation of hyphae growth in Candida albicans. Virulence, 11, 337\u2013348.","journal-title":"Virulence"},{"key":"4207_CR40","doi-asserted-by":"publisher","first-page":"1612661","DOI":"10.1080\/21688370.2019.1612661","volume":"7","author":"L Basmaciyan","year":"2019","unstructured":"Basmaciyan, L., Bon, F., Paradis, T., et al. (2019). Candida albicans interactions with the host: Crossing the intestinal epithelial barrier. Tissue Barriers, 7, 1612661.","journal-title":"Tissue Barriers"},{"issue":"4","key":"4207_CR41","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. P T, 40(4), 277\u201383.","journal-title":"P T"},{"key":"4207_CR42","unstructured":"Shalini, S. D. (2016). Global Markets for Drug Repurposing. Retrieved June\u00a024,\u00a02022,\u00a0from\u00a0https:\/\/www.bccresearch.com\/market-research\/pharmaceuticals\/drug-repurposing-markets-report.html"},{"key":"4207_CR43","unstructured":"Patricia, V. N. (2016). Drug Repurposing and Repositioning: Making New Out of Old, DCAT Value Chain Insights.\u00a0Retrieved June 24, 2022, from\u00a0https:\/\/www.dcatvci.org\/features\/drug-repurposing-and-repositioning-making-new-out-of-old"},{"key":"4207_CR44","unstructured":"Antibiotic market size, share & COVID-19 impact analysis forecast 2021\u20132028. A market research report by Fortune business insights. 2020;1\u2013166.\u00a0Retrieved June 24, 2022, from\u00a0https:\/\/www.fortunebusinessinsights.com\/antibiotics-market-104583"},{"issue":"2","key":"4207_CR45","doi-asserted-by":"publisher","first-page":"e0148951","DOI":"10.1371\/journal.pone.0148951","volume":"11","author":"A Mehta","year":"2016","unstructured":"Mehta, A., Hasan Farooqui, H., & Selvaraj, S. (2016). A critical analysis of concentration and competition in the Indian pharmaceutical market. PLoS One, 11(2), e0148951.","journal-title":"PLoS One"},{"issue":"2","key":"4207_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bph.13798","volume":"175","author":"Y Cha","year":"2018","unstructured":"Cha, Y., Erez, T., Reynolds, I. J., et al. (2018). Drug repurposing from the perspective of pharmaceutical companies. British Journal of Pharmacology, 175(2), 168\u2013180.","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"4207_CR47","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7150\/ijbs.24612","volume":"14","author":"H Xue","year":"2018","unstructured":"Xue, H., Li, J., Xie, H., et al. (2018). Review of drug repositioning approaches and resources. International Journal of Biological Sciences, 14(10), 1232\u20131244.","journal-title":"International Journal of Biological Sciences"},{"key":"4207_CR48","doi-asserted-by":"publisher","first-page":"329121","DOI":"10.1155\/2013\/329121","volume":"2013","author":"N Gurung","year":"2013","unstructured":"Gurung, N., Ray, S., Bose, S., et al. (2013). A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. Biomed Research International, 2013, 329121.","journal-title":"Biomed Research International"},{"key":"4207_CR49","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.5958\/0974-360X.2019.00594.8","volume":"12","author":"R Krishnaveni","year":"2019","unstructured":"Krishnaveni, R., & Meenambiga, S. S. (2019). In-silico analysis of endophytic fungal metabolites against secreted aspartic proteinase enzyme of Candida albicans. Research Journal of Pharmacy and Technology, 12, 3495\u20133500.","journal-title":"Research Journal of Pharmacy and Technology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-04207-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:08:36Z","timestamp":1701432516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-04207-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["4207"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-04207-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"21 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors have their consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have their consent to publish their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}